1397P High incidence of treatment-related adverse events after combination EGFR tyrosine-kinase inhibitor and immune checkpoint inhibitors in EGFR-mutated metastatic non-small cell lung cancer: A systematic review and meta-analysis
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI